Alessandro Riccombeni | Chief Executive Officer
Axia Medicine

Dr. Alessandro Riccombeni is the CEO and founder of Axia Medicine, a patient-centric Personalised Healthcare company. Alessandro has more than 16 years of international experience in business strategy, product development and research. Before creating Axia Medicine, Alessandro led the Precision Medicine investment strategy, sales pipeline and enablement programmes for both Amazon Web Services and Microsoft, including the creation of AWS' international Precision Medicine segment and Microsoft's only win in Population Genomics.
Alessandro led the creation of bioinformatics platforms and services for gene editing and multimodal data, including the creation of Big Tech's first original cloud service for Precision Medicine. At DNAnexus, Alessandro led the development of the EMEA market for Pharma and Diagnostics, as part of Andrew Carroll's team.
Alessandro is an advocate for Equity, Diversity and Inclusion, with an interest in social mobility and the creation of industry opportunities for young talent from disadvantaged backgrounds. He started his career in research, leading projects in Oncology and Infection Biology. Dr. Riccombeni holds a Ph. D. in Bioinformatics from University College Dublin and an MBA from London Business School.